SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Lenehan James T

(Last)

(First)

(Middle)

C/O TALECRIS BIOTHERAPEUTICS HOLDINGS

P.O. BOX 110526 4101 RESEARCH COMMONS

(Street)

RESEARCH TRIANGLE PARK

27709

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
09/30/2009

3. Issuer Name and Ticker or Trading Symbol
Talecris Biotherapeutics Holdings Corp. [ TLCR ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	136,872⁽¹⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Options (right to buy)	04/01/2006⁽²⁾	11/10/2015	Common Stock	527,200⁽²⁾	$1.39	D
Options (right to buy)	04/01/2009	04/21/2018	Common Stock	12,616	$9.88	D
Options (right to buy)	04/01/2010⁽³⁾	03/27/2019	Common Stock	7,848⁽³⁾	$16.63	D

Explanation of Responses:

1. The number of shares reflected in this row includes 42,392 shares that have not yet vested of the Issuer's common stock that were granted by the Issuer to the Reporting Person on December 6, 2006 and which will vest on March 31, 2010, subject to the Reporting Person's continuous service with the Issuer through that date, as detailed in a restricted stock award agreement by and between the Issuer and the Reporting Person, dated as of December 6, 2006. Also includes an additional 3,616 shares that have not yet vested of the Issuer's common stock that were granted by the Issuer to the Reporting Person on March 27, 2009 and which will vest on April 1, 2010, subject to the Reporting Person's continuous service with the Issuer through that date, as detailed in a restricted stock award agreement by and between the Issuer and the Reporting Person, dated as of March 27, 2009.

2. The securities being reported in this row are options to purchase the Issuer's common stock that were granted by the Issuer to the Reporting Person on November 10, 2005. 105,440 of these options have not vested and will vest and become exercisable on April 1, 2010, subject to the Reporting Person remaining a Key Person (as defined in the Issuer's 2005 Stock Option and Incentive Plan) with the Issuer through that date, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of November 10, 2005.

3. The securities being reported in this row are options to purchase the Issuer's common stock that were granted by the Issuer to the Reporting Person on March 27, 2009. These options will vest and become exercisable on April 1, 2010, subject to the Reporting Person remaining a Key Person (as defined in the Issuer's 2005 Stock Option and Incentive Plan) with the Issuer through that date, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of March 27, 2009.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

	/s/ John F. Gaither, Jr., attorney in fact	09/30/2009
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.